Acute PresentatiOn of CoLorectaL Cancer: an internatiOnal snapshot
ALL HOSPITALS | GENERAL SURGERY | SIX-WEEK DATA COLLECTION
The study is now recruiting sites.
What is the APOLLO Study?
APOLLO is an international, multi-centre, prospective observational cohort study of acutely presenting colorectal cancer exploring the operative and non-operative management of emergency presentations of colon and rectal cancer globally. The study is being delivered by the European Students Research Collaborative (EuroSurg), and will be facilitated in Australia and Aotearoa New Zealand by TASMAN and other local collaborative networks.
What Are APOLLO’s Main Objectives?
APOLLO is an international, prospective multi-centre cohort study that aims:
Describe the variation in the operative and non-operative management of emergency presentations of colon and rectal cancer in an international cohort.
Identify risk factors for mortality (intraoperatively, at 30-days and at 90-days) and ostomy rates (at 30- and 90-days) in patients deemed for active management (i.e., not for palliative management) to develop a risk prediction model
Validate risk criteria of large bowel obstruction in patients with previously known colorectal cancer undergoing neoadjuvant chemotherapy or awaiting elective surgery.
Through facilitating the APOLLO Study in Australia and Aotearoa New Zealand, we aim to build collaborative research capacity within medical students and junior doctors in ANZ.
Who is Involved?
TASMAN invites all medical students in their clinical years, junior doctors and consultants to become collaborators of this study. All collaborators will be included as PubMed-citable co-authors on resulting publications. All hospitals with adults presenting with known OR new diagnosis of colorectal cancer can participate in this study.